Four years after a single treatment, the high-dose AMT-130 group continues to show encouraging signs of slower HD progression ...
In plain language. Written by scientists. September brought progress across the HD research landscape. From brain waves and visual thinking to DNA repeats, nutrition, inclusive care, new technologies, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results